世界のRNA治療市場2020-2027:技術別(実現技術、有効技術)、用途別、エンドユーザー別、地域別

◆英語タイトル:Global RNA Based Therapeutics Market Size study, by Technology (Enabling Technologies, Enabled Technologies), by Application (Cardiovascular, Kidney Diseases, Oncology, Infectious Diseases, Metabolic disorders, Others), by End-User (Research, Therapeutics, Diagnosis) and Regional Forecasts 2020-2027
◆商品コード:BZW21AP017
◆発行会社(リサーチ会社):Bizwit Research&Consulting
◆発行日:2021年2月16日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、GCC諸国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research&Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research&Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、世界のRNA治療市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、技術別(実現技術(マイクロアレイ、ラベリング、精製、その他)、有効技術(例:RNA干渉(RNAi)技術、RNAアンチセンス技術)分析、用途別(心臓血管、腎臓病、腫瘍、感染症、代謝障害)分析、エンドユーザー別(研究、治療、診断)分析、地域別分析、競争状況、調査プロセスなどを整理しました。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・世界のRNA治療市場規模:技術別(実現技術(マイクロアレイ、ラベリング、精製、その他)、有効技術(例:RNA干渉(RNAi)技術、RNAアンチセンス技術)
・世界のRNA治療市場規模:用途別(心臓血管、腎臓病、腫瘍、感染症、代謝障害)
・世界のRNA治療市場規模:エンドユーザー別(研究、治療、診断)
・世界のRNA治療市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global RNA Based Therapeutics Market is valued at approximately USD 0.93 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 28.4% over the forecast period 2020-2027. Healthcare sector have undertaken their attention to bring constancy to the RNA molecules in the body with limited bioavailability. For this, RNA therapeutics is being developed and when combined with protein/lipid nanoparticles deliver better stability. Despite being in a clinical research phase, the RNA therapeutics is being extensively discovered with a primary target to find a cure for unmet medical circumstances and rare diseases. Since, this field is significantly based on research, the advancements in technology assist in expanding the market and its geographical area. Advancement of promising technologies, such as antisense technology, RNAi interference technology, and smart technology that provides optimistic future growth prospect to the market in the forthcoming period. Furthermore, the rise in prevalence of infectious diseases, along with the more intense product focus against technology are the few factors responsible for the high CAGR of the market during the forecast period.

According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, there were 1.7 million people were newly influenced by HIV, as compared to a 2.8 million population of adults in 1998. Similarly, in August 2018, BioNTech AG has entered into a research and development (R&D) collaboration with Pfizer to develop Messenger RNA (mRNA) -based influenza vaccines. These exciting strategic collaborations and partnerships lead to pioneering developments in the RNA-based therapeutics field. This, in turn, is expected to strengthen the market growth all over the world. However, the high cost of research and risk of failure, coupled with complications in drug delivery are the few major factors limiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global RNA Based Therapeutics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rapid adoption of new technologies and therapeutic for drug delivery, along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in number of patients with chronic diseases, such as cancer and cardiovascular diseases, along with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the RNA Based Therapeutics market across the Asia-Pacific region.

Major market player included in this report are:
Quark Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc.
Tekmira Pharmaceuticals Corp.
Benitec Biopharma Limited
Cenix BioScience GmbH
Genzyme Corporation
Silence Therapeutics PLC
Sirnaomics, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Technology:
Enabling technologies (such as microarrays, labeling, purification, and others)
Enabled technologies (e.g., RNA Interference (RNAi) technologies and RNA antisense technologies)

By Application:
Cardiovascular
Kidney Diseases
Oncology
Infectious diseases
Metabolic disorders
Others

By End-User:
Research
Therapeutics
Diagnosis

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global RNA Based Therapeutics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. RNA Based Therapeutics Market, by Region, 2018-2027 (USD Billion)
1.2.2. RNA Based Therapeutics Market, by Technology, 2018-2027 (USD Billion)
1.2.3. RNA Based Therapeutics Market, by Application, 2018-2027 (USD Billion)
1.2.4. RNA Based Therapeutics Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global RNA Based Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global RNA Based Therapeutics Market Dynamics
3.1. RNA Based Therapeutics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global RNA Based Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global RNA Based Therapeutics Market, by Technology
5.1. Market Snapshot
5.2. Global RNA Based Therapeutics Market by Technology, Performance – Potential Analysis
5.3. Global RNA Based Therapeutics Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
5.4. RNA Based Therapeutics Market, Sub Segment Analysis
5.4.1. Enabling technologies (such as microarrays, labeling, purification, and others)
5.4.2. Enabled technologies (e.g., RNA Interference (RNAi) technologies and RNA antisense technologies)
Chapter 6. Global RNA Based Therapeutics Market, by Application
6.1. Market Snapshot
6.2. Global RNA Based Therapeutics Market by Application, Performance – Potential Analysis
6.3. Global RNA Based Therapeutics Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
6.4. RNA Based Therapeutics Market, Sub Segment Analysis
6.4.1. Cardiovascular
6.4.2. Kidney Diseases
6.4.3. Oncology
6.4.4. Infectious diseases
6.4.5. Metabolic disorders
6.4.6. Others
Chapter 7. Global RNA Based Therapeutics Market, by End-User
7.1. Market Snapshot
7.2. Global RNA Based Therapeutics Market by End-User – Potential Analysis
7.3. Global RNA Based Therapeutics Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
7.4. RNA Based Therapeutics Market, Sub Segment Analysis
7.4.1. Research
7.4.2. Therapeutics
7.4.3. Diagnosis
Chapter 8. Global RNA Based Therapeutics Market, Regional Analysis
8.1. RNA Based Therapeutics Market, Regional Market Snapshot
8.2. North America RNA Based Therapeutics Market
8.2.1. U.S. RNA Based Therapeutics Market
8.2.1.1. Technology breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. End-User breakdown estimates & forecasts, 2017-2027
8.2.2. Canada RNA Based Therapeutics Market
8.3. Europe RNA Based Therapeutics Market Snapshot
8.3.1. U.K. RNA Based Therapeutics Market
8.3.2. Germany RNA Based Therapeutics Market
8.3.3. France RNA Based Therapeutics Market
8.3.4. Spain RNA Based Therapeutics Market
8.3.5. Italy RNA Based Therapeutics Market
8.3.6. Rest of Europe RNA Based Therapeutics Market
8.4. Asia-Pacific RNA Based Therapeutics Market Snapshot
8.4.1. China RNA Based Therapeutics Market
8.4.2. India RNA Based Therapeutics Market
8.4.3. Japan RNA Based Therapeutics Market
8.4.4. Australia RNA Based Therapeutics Market
8.4.5. South Korea RNA Based Therapeutics Market
8.4.6. Rest of Asia Pacific RNA Based Therapeutics Market
8.5. Latin America RNA Based Therapeutics Market Snapshot
8.5.1. Brazil RNA Based Therapeutics Market
8.5.2. Mexico RNA Based Therapeutics Market
8.6. Rest of The World RNA Based Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Quark Pharmaceuticals, Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Alnylam Pharmaceuticals, Inc.
9.2.3. Dicerna Pharmaceuticals, Inc.
9.2.4. Tekmira Pharmaceuticals Corp.
9.2.5. Benitec Biopharma Limited
9.2.6. Cenix BioScience GmbH
9.2.7. Genzyme Corporation
9.2.8. Silence Therapeutics PLC
9.2.9. Sirnaomics, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global RNA Based Therapeutics market, report scope
TABLE 2. Global RNA Based Therapeutics market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global RNA Based Therapeutics market estimates & forecasts by Technology 2017-2027 (USD Billion)
TABLE 4. Global RNA Based Therapeutics market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 5. Global RNA Based Therapeutics market estimates & forecasts by End-User 2017-2027 (USD Billion)
TABLE 6. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global RNA Based Therapeutics market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Global RNA Based Therapeutics market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. U.S. RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. U.S. RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. Canada RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 26. Canada RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. Canada RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. UK RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 29. UK RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. UK RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. Germany RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 32. Germany RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. Germany RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. France RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 35. France RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. France RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. Spain RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 38. Spain RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Spain RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Italy RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 41. Italy RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. Italy RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. ROE RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 44. ROE RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. ROE RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. China RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 47. China RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. China RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. India RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 50. India RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. India RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. Japan RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 53. Japan RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Japan RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Australia RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 56. Australia RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. Australia RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 58. South Korea RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 59. South Korea RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. South Korea RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 61. ROPAC RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 62. ROPAC RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. ROPAC RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 64. Brazil RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 65. Brazil RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Brazil RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 67. Mexico RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 68. Mexico RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. Mexico RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 70. ROLA RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 71. ROLA RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROLA RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 73. ROW RNA Based Therapeutics market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 74. ROW RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. ROW RNA Based Therapeutics market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 76. List of secondary sources, used in the study of global RNA Based Therapeutics market
TABLE 77. List of primary sources, used in the study of global RNA Based Therapeutics market
TABLE 78. Years considered for the study
TABLE 79. Exchange rates considered

List of figures
FIG 1. Global RNA Based Therapeutics market, research methodology
FIG 2. Global RNA Based Therapeutics market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global RNA Based Therapeutics market, key trends 2019
FIG 5. Global RNA Based Therapeutics market, growth prospects 2020-2027
FIG 6. Global RNA Based Therapeutics market, porters 5 force Model
FIG 7. Global RNA Based Therapeutics market, pest analysis
FIG 8. Global RNA Based Therapeutics market, value chain analysis
FIG 9. Global RNA Based Therapeutics market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global RNA Based Therapeutics market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global RNA Based Therapeutics market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global RNA Based Therapeutics market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global RNA Based Therapeutics market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global RNA Based Therapeutics market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global RNA Based Therapeutics market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global RNA Based Therapeutics market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global RNA Based Therapeutics market, regional snapshot 2017 & 2027
FIG 18. North America RNA Based Therapeutics market 2017 & 2027 (USD Billion)
FIG 19. Europe RNA Based Therapeutics market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific RNA Based Therapeutics market 2017 & 2027 (USD Billion)
FIG 21. Latin America RNA Based Therapeutics market 2017 & 2027 (USD Billion)
FIG 22. Global RNA Based Therapeutics market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のRNA治療市場2020-2027:技術別(実現技術、有効技術)、用途別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆